Market Mover: Caredx (CDNA) Up at Midday June 22

Equities Staff  |

Shares of Caredx Inc (NASDAQ: CDNA) climbed 6.05% Wednesday.

As of 11:50:59 est, Caredx sits at $21.88 and has risen $1.25 per share in trading so far.

Caredx has moved 20.15% over the last 30 days and has moved YTD 54.60% based on the most recent close.

The company expects its next earnings on 2022-07-28.

For technical charts, analysis, and more on Caredx visit the company profile.

About Caredx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.

To get more information on Caredx Inc and to follow the company's latest updates, you can visit the company's profile page here: Caredx Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content